Home › Trials › NCT07320664
Clinical trial Recruiting at 1 site Interventional Ages 18 to 25 Women only

Tracking risk awareness and improving knowledge about alcohol-related breast cancer in young adult women

Official title: Alcohol Counter Marketing as a Breast Cancer Prevention Strategy in Young Women

Run by Ohio State University Comprehensive Cancer Center · NCT07320664 · Data updated 2026-11-12

This project will test whether co-created digital messages can reduce drinking and increase young women's awareness that alcohol raises breast cancer risk.

Quick facts

Study typeInterventional
Ages18 Years to 25 Years
SexWomen only
Enrollment500 (estimated)
SponsorOhio State University Comprehensive Cancer Center
Academic / other
Locations1 site (Columbus, Ohio)
StatusRecruiting
StartedMarch 19, 2026
Main results expectedJuly 1, 2027
Study endsJuly 1, 2027
Registry record updatedMarch 25, 2026
Trial IDNCT07320664 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Eligible participants are people assigned female at birth, aged 18–25, who drank alcohol at least once in the past 30 days, are not pregnant or planning pregnancy, live in Ohio, Michigan, Illinois, Wisconsin, or New Jersey, and can receive smartphone text/image messages (with iPhone required for the biosensor subgroup).

Probably not a fit

People who do not drink, are pregnant or intending pregnancy, are outside the 18–25 age range, are assigned male at birth, or live outside the eligible states are not eligible and therefore would not receive benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized behavioral trial enrolls women assigned female at birth aged 18–25 who have consumed alcohol in the past 30 days and live in five Midwestern/Atlantic states. Participants are randomized 1:1 to receive co-created counter-marketing messages about alcohol and breast cancer twice weekly for six weeks or to a control arm receiving text-only skin cancer risk/prevention messages at the same dose. The intervention content was co-created with young adult women using real-time discussions and AI text-to-image tools and was refined before testing. Up to 10% of participants in each arm will be randomly selected to wear a wrist-worn transdermal alcohol biosensor (iPhone required for that subgroup) to capture objective drinking measures remotely.

Why it matters

Potential benefit: If successful, this approach could reduce alcohol use and increase understanding of alcohol-related breast cancer risk among young adult women, potentially lowering future cancer risk.

How similar studies have gone: Prior digital brief interventions and counter-marketing approaches have shown modest success in changing young adults' alcohol-related attitudes and behaviors, but the specific use of co-created AI-generated counter-marketing content is novel and less tested.

Who can join: the full rules

Show full inclusion / exclusion criteria 
Inclusion Criteria:

* Assigned female at birth.
* Age 18-25 at enrollment.
* Report drinking alcohol at least once in the past 30 days.
* Not pregnant or intending to become pregnant by self-report.
* Reside in Ohio, Michigan, Illinois, Wisconsin, or New Jersey.
* Willing to complete procedures.
* Able to complete procedures a, b, or c:

  1. Can read, write, and converse in English.
  2. Has a personal mobile smartphone with texting capabilities to receive text messages that may contain text and images.
  3. For the subsample who will wear the BACTrack sensor, they must have an iPhone. At the time of this protocol, the BACTrack skyn app is only compatible with iPhones. If this expands to Android phones over the course of the study, Android phones will be eligible.

Exclusion Criteria:

* Assigned male at birth
* Ages \<18 or \>25 at enrollment
* Do not report drinking alcohol at least once in the past 30 days
* Pregnant or intending to become pregnant by self-report.
* Do not reside in Ohio, Michigan, Illinois, Wisconsin, or New Jersey.
* Not willing to complete procedures.
* Unable to complete procedures.

Where it's running

  • Ohio State University Comprehensive Cancer Center
    Columbus, Ohio, United States     Recruiting

Study contacts

  • Principal investigator: Darren Mays, MPH, PhD — Ohio State University Comprehensive Cancer Center
  • Study coordinator: The Ohio State University Comprehensive Cancer Center
  • Email: OSUCCCClinicaltrials@osumc.edu
  • Phone: 800-293-5066

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov ↗ Find more trials like this →
Browse more
Behavior, Risk 2Ohio State University Comprehensive Cancer Center 107
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.